Trump's selection of Dr. Jay Bhattacharya, known for his controversial stance on COVID-19, signals an unusual direction in leadership for the NIH.
As a strong advocate for herd immunity, Bhattacharya has faced opposition from many experts during the COVID-19 pandemic, illustrating the polarized views on health policy.
Together with Robert F. Kennedy Jr., Bhattacharya aims to restore NIH's reputation, focusing on chronic illness and disease solutions beyond traditional methods.
Bhattacharya's background in health policy and economics, combined with his Stanford connections, positions him uniquely to influence the future of American health policy.
Collection
[
|
...
]